Pharmaceutical industry says Europe must ‘embrace new approaches to research and regulation’
The European Cancer Plan being developed by the European Commission must tackle all aspects of cancer prevention, treatment and care, a senior pharmaceutical industry representative has said.
Europe must “embrace new approaches to clinical research and regulation, healthcare technology assessment and decision-making”, Nathalie Moll, director general of the European Federation of Pharmaceutical Industries and Associations, said in a blog post published on 15 January.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.